Latest Breaking News On - Serum neurofilament - Page 1 : comparemela.com

Immunic to Participate in Investor and Scientific Conferences in May

NEW YORK, May 6, 2024 /PRNewswire/ Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and.

United statesSofiya gradJessica breuEdna kaplanPaula schwartzSonya ivanova hristova chakmakovaRobertj foxFranziska buriExchange commissionMellen centerResearch forumNational congressNeurological instituteRx communications groupConsortium of multiple sclerosis centersImmunic inc

EQS-News: Immunic AG: Immunic to Participate in Investor and Scientific Conferences in May

EQS-News: Immunic AG: Immunic to Participate in Investor and Scientific Conferences in May
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSofiya gradFranziska buriEdna kaplanJessica breuSonya ivanova hristova chakmakovaPaula schwartzRobertj foxExchange commissionTheconsortium of multiple sclerosis centersDistribution servicesRx communications groupResearch forumNeurological instituteImmunic incMellen center

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittRobertj foxAlexandra herrmannResearch in multiple sclerosisNeurological instituteMellen centerImmunic incAmericas committee for treatmentAmericas committeeMultiple sclerosisPalm beachChief executive officerVidofludimus calciumSerum neurofilamentStaff neurologist

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittRobertj foxAlexandra herrmannMellen centerExchange commissionNeurological instituteResearch in multiple sclerosisAmericas committee for treatmentImmunic incAmericas committeeMultiple sclerosisPalm beach

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanRobertj foxJessica breuAlexandra herrmannPaula schwartzDaniel vittMellen centerAmericas committee for treatmentResearch in multiple sclerosisNeurological instituteImmunic incExchange commissionDistribution servicesRx communications groupPresents data from phase